Securing Europe’s Antibiotic Supply: A More Functional Future
October 31, 2025
The latest New Angle report discusses the status of Europe’s antibiotics supply chain, and how structural reform at the policy level is required to rectify it.
3 min read
False
Advertisement
Regulation & Standards
MDIs and the Need for Greener Propellants
By Stephanie Vine, Julian Upton
October 27, 2025
Regulations are pushing companies to more environmentally friendly propellants, but how should capacity be scaled up?
5 min read
Reimagining LSD to Treat Mental Health Disorders
By Stephanie Vine
October 24, 2025
We speak with a biotech CEO about the potential of psychedelic medicine – and the challenges of working with stigmatized substances.
11 min read
Made in Africa, For Global Good
By Stephanie Vine
October 23, 2025
Interviewing Quarraisha Abdool Karim – one of the world’s most influential HIV scientists
10 min read
The Cell & Gene Circuit: Keeping Up With Advancing Therapies and Technologies
October 22, 2025
Cell and gene therapy is advancing faster than ever, powered by breakthroughs in AI, automation, and CRISPR technology. But as some companies double down and others step back, the race to deliver real-world impact is intensifying.
4 min read
Tariffs, Talent, and Technology: Inside Pharma’s Executive Recruitment Landscape
October 22, 2025
As tariffs and geopolitical uncertainty continue to disrupt supply chains, a new kind of biotech and pharma executive is emerging.
7 min read
The Mindset of Science for Humanity
October 17, 2025
Quarraisha Abdool Karim discusses COVID-19 and why the industry must continue to invest in mRNA – and take the public along with them
11 min read
Mastering Microbial Cell Banking & Characterization
October 16, 2025
Join us for an insightful webinar on cell banking and characterization where we will explore relevant regulatory guidelines for biologics manufacturers.
Thursday, October 16, 2025 min read
How Do We Build Trust and Transparency in AI?
By Jo Varshney
October 14, 2025
AI is fast tracking new therapies, but speed means nothing if we can't trust the systems.
4 min read
What Happened at Meeting on the Mesa 2025?
October 14, 2025
This year’s Meeting on the Mesa showed that cell and gene therapy is no longer defined by hype, but by hard work– from digital manufacturing to creative funding models and policy alignment.
4 min read
